Adenocarcinoma of the Esophagus Withdrawn Phase 1 / 2 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0030040 (Adenocarcinoma of the Esophagus)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02344810C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal CancerTreatment